Fresenius Medical Care AG & Co. KGaA (FME) Given a €102.00 Price Target at Nord/LB

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €102.00 ($118.60) target price from analysts at Nord/LB in a research note issued to investors on Monday. The brokerage currently has a “buy” rating on the stock. Nord/LB’s target price points to a potential upside of 17.70% from the company’s current price.

Other equities research analysts have also issued research reports about the stock. DZ Bank set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Wednesday, January 31st. Berenberg Bank set a €101.00 ($117.44) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, February 27th. JPMorgan Chase & Co. set a €95.60 ($111.16) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, February 27th. Goldman Sachs Group set a €97.00 ($112.79) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, February 27th. Finally, Credit Suisse Group set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Thursday, February 22nd. Eight equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of “Buy” and an average price target of €93.65 ($108.89).

Shares of FME remained flat at $€86.66 ($100.77) during mid-day trading on Monday. 316,717 shares of the company were exchanged, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €75.53 ($87.83) and a 12-month high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply